Search
Showing results for "Au"
Research
Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm InfantsJennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical
Research
Targeting DYRK1A: a key player in Down syndrome LeukaemogenesisSébastien Malinge PhD Laboratory Head, Translational Genomics in Leukaemia, Ursula Kees Fellow (CCRF), Cancer Council WA Fellow (CCWA), Senior
News & Events
Autism research innovator shortlisted for Eureka PrizeDr Andrew Whitehouse from Perth's Telethon Institute for Child Health Research shortlisted as a finalist for the prestigious 2012 Australian Museum Eureka Prize
News & Events
National focus on Fetal Alcohol Spectrum Disorders welcomedLeading researchers into the effects of alcohol in pregnancy have thrown their support behind the recommendations of a national Inquiry into FASD.
Research
A phase 3, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety and tolerability of V114 in healthy infants (PNEULINK)Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical
Research
Early Years Strategic Priority – Scoping and Mapping of the South Australian Early Years SystemYasmin Harman-Smith BA, BHlthSc(Hons), PhD Head, Early Years Systems Evidence; Head, Tenders Support Unit Yasmin.harman-smith@thekids.org.au Head,
The Opportunity Led by Professor Andrew Whitehouse, the Autism Research Team, based at The Kids Research Institute Australia, are international
Develop, implement and evaluate strategies for FASD prevention in collaboration with Aboriginal organisations, researchers, health promotion officers
Applicant must have solid experience in tissue culture, in vivo techniques, flow cytometry and molecular biology.
